A new CBD gel is being tested on patients in New Zealand with a specific form of epilepsy – ZYN002 is a non-THC topical gel from Zynerba Pharmaceuticals.
“The NZ government’s approval of this trial to assess a new cannabis gel for treatment of seizures, is an important step forward in the NZ government’s recognition of the potential of cannabis and various cannabinoids for medical purposes,” said Sue Grey, a New Zealand lawyer. Grey has recently been flooded with requests from medical marijuana patients in need of legal defense.
It’s not the norm, as the availability of cannabinoids for therapeutic use in New Zealand is slim to none.
RELATED ARTICLE: Meet New Zealand’s Most Influential Cannabis Activist
Abe Gray is a radio personality, researcher, and curator of New Zealand’s only cannabis museum. He’s skeptical, at best, that this will change the